{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:40:01Z","timestamp":1760676001135,"version":"build-2065373602"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00520-025-09993-7","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:31:23Z","timestamp":1759584683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health utility book: A systematic review and meta-analysis of health utilities in gastric cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Shant Torkom","family":"Yeretzian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiranjeev","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Simbulan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Manja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preston","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Zoratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"issue":"8","key":"9993_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11894-017-0575-8","volume":"19","author":"M Balakrishnan","year":"2017","unstructured":"Balakrishnan M et al (2017) Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep 19(8):36","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"9993_CR2","first-page":"26","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Barsouk A (2019) Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 14(1):26\u201338","journal-title":"Prz Gastroenterol"},{"key":"9993_CR3","doi-asserted-by":"publisher","first-page":"101727","DOI":"10.1016\/j.bpg.2021.101727","volume":"50\u201351","author":"K Sch\u00fctte","year":"2021","unstructured":"Sch\u00fctte K, Schulz C, Middelberg-Bisping K (2021) Impact of gastric cancer treatment on quality of life of patients. Best Pract Res Clin Gastroenterol 50\u201351:101727","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"9993_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10120-020-01131-y","volume":"24","author":"K Fujitani","year":"2021","unstructured":"Fujitani K et al (2021) Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial. Gastric Cancer 24:467\u2013476","journal-title":"Gastric Cancer"},{"key":"9993_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S305939","author":"R-D Hofheinz","year":"2021","unstructured":"Hofheinz R-D et al (2021) Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types. Cancer Manag Res. https:\/\/doi.org\/10.2147\/CMAR.S305939","journal-title":"Cancer Manag Res"},{"issue":"24","key":"9993_CR6","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.2217\/fon-2021-0199","volume":"17","author":"M Soni","year":"2021","unstructured":"Soni M et al (2021) Nivolumab in gastric\/gastroesophageal junction cancer: real-world data from UK early access to medicines scheme. Future Oncol 17(24):3163\u20133174","journal-title":"Future Oncol"},{"issue":"4","key":"9993_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10120-022-01309-6","volume":"25","author":"A Rowsell","year":"2022","unstructured":"Rowsell A et al (2022) Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences. Gastric Cancer 25(4):665\u2013677","journal-title":"Gastric Cancer"},{"key":"9993_CR8","unstructured":"Gold MR, editor. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. 425 p"},{"key":"9993_CR9","unstructured":"EuroQol Research Foundation . Value sets. 2020"},{"key":"9993_CR10","unstructured":"Canadian Agency for Drug and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies [Internet]. 4th Edition. 2017. Available from:https:\/\/www.cadth.ca\/sites\/default\/files\/pdf\/guidelines_for_the_economic_evaluation_of_health_technologies_canada_4th_ed.pdf."},{"key":"9993_CR11","unstructured":"Pharmaceutical Benefit Coverage Assessment Committee. Overview and rationale of the economic evaluation. 2024 [cited 2024 May 9]; Available from: https:\/\/pbac.pbs.gov.au\/section-3a\/3a-1-overview-and-rationale-of-economic-evaluation.html."},{"key":"9993_CR12","unstructured":"Theakston C et al. The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region. 2025, Office of Health Economics"},{"issue":"5","key":"9993_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/bmjebm-2022-112098","volume":"28","author":"B Humphries","year":"2023","unstructured":"Humphries B et al (2023) Decision analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed-methods pilot study. BMJ Evidence-Based Med 28(5):309","journal-title":"BMJ Evidence-Based Med"},{"issue":"11","key":"9993_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3111\/13696998.2015.1066380","volume":"18","author":"GC Carter","year":"2015","unstructured":"Carter GC et al (2015) Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review. J Med Econ 18(11):954\u2013966","journal-title":"J Med Econ"},{"key":"9993_CR15","doi-asserted-by":"publisher","first-page":"103069","DOI":"10.1016\/j.critrevonc.2020.103069","volume":"154","author":"HG van den Boorn","year":"2020","unstructured":"van den Boorn HG et al (2020) Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 154:103069","journal-title":"Crit Rev Oncol Hematol"},{"key":"9993_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235934","author":"RM van Amelsfoort","year":"2021","unstructured":"van Amelsfoort RM et al (2021) Health-related quality of life in locally advanced gastric cancer: a systematic review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13235934","journal-title":"Cancers (Basel)"},{"issue":"4","key":"9993_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1177\/0272989X19837969","volume":"39","author":"F Xie","year":"2019","unstructured":"Xie F et al (2019) Toward a centralized, systematic approach to the identification, appraisal, and use of health state utility values for reimbursement decision making: introducing the health utility book (HUB). Med Decis Making 39(4):370\u2013378","journal-title":"Med Decis Making"},{"issue":"2","key":"9993_CR18","doi-asserted-by":"publisher","first-page":"238146831985259","DOI":"10.1177\/2381468319852594","volume":"4","author":"MJ Zoratti","year":"2019","unstructured":"Zoratti MJ et al (2019) Health utility book (HUB)\u2013cancer: protocol for a systematic literature review of health state utility values in cancer. MDM Policy & Practice 4(2):2381468319852594","journal-title":"MDM Policy & Practice"},{"issue":"2","key":"9993_CR19","doi-asserted-by":"publisher","first-page":"238146831985259","DOI":"10.1177\/2381468319852594","volume":"4","author":"MJ Zoratti","year":"2019","unstructured":"Zoratti MJ et al (2019) Health utility book (HUB)-cancer: protocol for a systematic literature review of health state utility values in cancer. MDM Policy Pract 4(2):2381468319852594","journal-title":"MDM Policy Pract"},{"key":"9993_CR20","first-page":"n71","volume":"372","author":"JP Matthew","year":"2021","unstructured":"Matthew JP et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"10251","key":"9993_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC et al (2020) Gastric cancer. Lancet 396(10251):635\u2013648","journal-title":"Lancet"},{"key":"9993_CR22","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S151946","author":"H-J Lee","year":"2018","unstructured":"Lee H-J et al (2018) Estimation of population-based utility weights for gastric cancer-related health states. Patient Prefer Adherence. https:\/\/doi.org\/10.2147\/PPA.S151946","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"9993_CR23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10198-022-01523-0","volume":"24","author":"C-W Pan","year":"2023","unstructured":"Pan C-W et al (2023) Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. Eur J Health Econ 24(6):885\u2013893","journal-title":"Eur J Health Econ"},{"issue":"7","key":"9993_CR24","doi-asserted-by":"publisher","first-page":"8024","DOI":"10.21037\/apm-21-1599","volume":"10","author":"F-F Zhang","year":"2021","unstructured":"Zhang F-F et al (2021) Evaluating health-related quality of life in gastric cancer patients in Suzhou, China. Annal Palliative Med 10(7):8024\u20138033","journal-title":"Annal Palliative Med"},{"key":"9993_CR25","unstructured":"Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"9993_CR26","first-page":"40","volume":"7","author":"G Schwarzer","year":"2007","unstructured":"Schwarzer G (2007) meta: An R package for meta-analysis. R news 7(3):40\u201345","journal-title":"R news"},{"key":"9993_CR27","doi-asserted-by":"crossref","unstructured":"Wickham H (2011) ggplot2. Wiley interdisciplinary reviews: computational statistics. 3(2):180-185","DOI":"10.1002\/wics.147"},{"key":"9993_CR28","doi-asserted-by":"publisher","first-page":"e079890","DOI":"10.1136\/bmj-2024-079890","volume":"385","author":"SG Karam","year":"2024","unstructured":"Karam SG et al (2024) ROBVALU: a tool for assessing risk of bias in studies about people\u2019s values, utilities, or importance of health outcomes. BMJ 385:e079890","journal-title":"BMJ"},{"key":"9993_CR29","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1200\/GO.20.00234","volume":"6","author":"M Iskedjian","year":"2020","unstructured":"Iskedjian M et al (2020) Elicitation of health utilities in oncology in the Kingdom of Saudi Arabia. JCO Glob Oncol 6:1609\u20131616","journal-title":"JCO Glob Oncol"},{"issue":"6","key":"9993_CR30","first-page":"e13283","volume":"29","author":"R Xia","year":"2020","unstructured":"Xia R et al (2020) Health-related quality of life and health utility score of patients with gastric cancer: a multi-centre cross-sectional survey in China. Eur J Cancer Care 29(6):e13283","journal-title":"Eur J Cancer Care"},{"issue":"721","key":"9993_CR31","doi-asserted-by":"publisher","first-page":"e571","DOI":"10.3399\/BJGP.2021.0700","volume":"72","author":"A Canny","year":"2022","unstructured":"Canny A et al (2022) Advance care planning in primary care for patients with gastrointestinal cancer: feasibility randomised trial. Br J Gen Pract 72(721):e571\u2013e580","journal-title":"Br J Gen Pract"},{"key":"9993_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10120-017-0754-1","volume":"21","author":"AJ Martin","year":"2018","unstructured":"Martin AJ et al (2018) Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma. Gastric Cancer 21:473\u2013480","journal-title":"Gastric Cancer"},{"key":"9993_CR33","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s10120-021-01179-4","volume":"24","author":"Y Ito","year":"2021","unstructured":"Ito Y et al (2021) QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study. Gastric Cancer 24:1131\u20131139","journal-title":"Gastric Cancer"},{"key":"9993_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7531545","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Changes in patient-reported health status in advanced cancer patients from a symptom management clinic: a longitudinal study conducted in China. J Oncol. https:\/\/doi.org\/10.1155\/2022\/7531545","journal-title":"J Oncol"},{"key":"9993_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2607829","author":"H Zhang","year":"2022","unstructured":"Zhang H et al (2022) Health-related quality of life and utility scores of posttreatment patients with gastric cancer at different pathological stages: a cross-sectional study. J Oncol. https:\/\/doi.org\/10.1155\/2022\/2607829","journal-title":"J Oncol"},{"issue":"2","key":"9993_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamasurg.2022.6337","volume":"158","author":"A van der Veen","year":"2023","unstructured":"van der Veen A et al (2023) Cost-effectiveness of laparoscopic vs open gastrectomy for gastric cancer: an economic evaluation alongside a randomized clinical trial. JAMA Surg 158(2):120\u2013128","journal-title":"JAMA Surg"},{"issue":"6","key":"9993_CR37","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10198-021-01411-z","volume":"23","author":"A Wang","year":"2022","unstructured":"Wang A et al (2022) The remarkably frequent use of EQ-5D in non-economic research. Eur J Health Econ 23(6):1007\u20131014","journal-title":"Eur J Health Econ"},{"issue":"10","key":"9993_CR38","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20(10):1727\u20131736","journal-title":"Qual Life Res"},{"issue":"3","key":"9993_CR39","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11136-016-1483-3","volume":"26","author":"C Mukuria","year":"2017","unstructured":"Mukuria C et al (2017) Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of phase III trials of adjunctive brivaracetam. Qual Life Res 26(3):749\u2013759","journal-title":"Qual Life Res"},{"issue":"7","key":"9993_CR40","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1023\/B:QURE.0000037498.00754.b8","volume":"13","author":"FMK Paul","year":"2004","unstructured":"Paul FMK et al (2004) Responsiveness of the Generic EQ-5D Summary Measure Compared to the Disease-Specific EORTC QLQ C-30. Qual Life Res 13(7):1247\u20131253","journal-title":"Qual Life Res"},{"issue":"1","key":"9993_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jval.2018.05.010","volume":"22","author":"E Stolk","year":"2019","unstructured":"Stolk E et al (2019) Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value Health 22(1):23\u201330","journal-title":"Value Health"},{"issue":"1","key":"9993_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12962-018-0103-1","volume":"16","author":"J Mahlich","year":"2018","unstructured":"Mahlich J et al (2018) Cultural beliefs, utility values, and health technology assessment. Cost Eff Resour Alloc 16(1):19","journal-title":"Cost Eff Resour Alloc"},{"issue":"11","key":"9993_CR43","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jval.2018.04.1370","volume":"21","author":"L Zhuo","year":"2018","unstructured":"Zhuo L et al (2018) Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey. Value Health 21(11):1330\u20131337","journal-title":"Value Health"},{"issue":"5","key":"9993_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jval.2014.05.007","volume":"17","author":"GG Liu","year":"2014","unstructured":"Liu GG et al (2014) Chinese time trade-off values for EQ-5D health states. Value Health 17(5):597\u2013604","journal-title":"Value Health"},{"key":"9993_CR45","unstructured":"Xie S-T et al. (2020) Review of generic preference-based scales for health-related quality of life at the universal scale. Chin J Health Policy 58\u201368"},{"issue":"10","key":"9993_CR46","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40273-022-01151-9","volume":"40","author":"J Wu","year":"2022","unstructured":"Wu J et al (2022) China health related outcomes measures (CHROME): development of a new generic preference-based measure for the Chinese population. Pharmacoeconomics 40(10):957\u2013969","journal-title":"Pharmacoeconomics"},{"key":"9993_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092639","author":"WS Shin","year":"2023","unstructured":"Shin WS et al (2023) Updated epidemiology of gastric cancer in Asia: decreased incidence but still a big challenge. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15092639","journal-title":"Cancers (Basel)"},{"issue":"4","key":"9993_CR48","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11136-012-0200-0","volume":"22","author":"N Luo","year":"2013","unstructured":"Luo N et al (2013) Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach. Qual Life Res 22(4):885\u2013890","journal-title":"Qual Life Res"},{"issue":"2","key":"9993_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/A:1008981520920","volume":"9","author":"H Zhao","year":"2000","unstructured":"Zhao H, Kanda K (2000) Translation and validation of the standard Chinese version of the EORTC QLQ-C30. Qual Life Res 9(2):129\u2013137","journal-title":"Qual Life Res"},{"issue":"1","key":"9993_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12955-017-0641-9","volume":"15","author":"MC Cnossen","year":"2017","unstructured":"Cnossen MC et al (2017) Comparing health-related quality of life of Dutch and Chinese patients with traumatic brain injury: do cultural differences play a role? Health Qual Life Outcomes 15(1):72","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"9993_CR51","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jval.2020.12.014","volume":"24","author":"Z Mao","year":"2021","unstructured":"Mao Z et al (2021) The unfolding method to explore health-related quality of life constructs in a Chinese general population. Value Health 24(6):846\u2013854","journal-title":"Value Health"},{"issue":"7","key":"9993_CR52","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0277-9536(02)00503-8","volume":"57","author":"A Bowden","year":"2003","unstructured":"Bowden A, Fox-Rushby JA (2003) A systematic and critical review of the process of translation and adaptation of generic health-related quality of life measures in Africa, Asia, Eastern Europe, the Middle East, South America. Soc Sci Med 57(7):1289\u20131306","journal-title":"Soc Sci Med"},{"key":"9993_CR53","doi-asserted-by":"publisher","first-page":"08001","DOI":"10.7189\/jogh.11.08001","volume":"11","author":"Q Yao","year":"2021","unstructured":"Yao Q et al (2021) Population norms for the EQ-5D-3L in China derived from the 2013 National Health Services Survey. J Glob Health 11:08001","journal-title":"J Glob Health"},{"issue":"1","key":"9993_CR54","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1186\/s12889-024-20999-4","volume":"24","author":"S Xie","year":"2024","unstructured":"Xie S et al (2024) The generic version of China Health Related Outcomes Measures (CHROME-G): psychometric testing and comparative performance with the EQ-5D-5L and SF-6Dv2 among the Chinese general population. BMC Public Health 24(1):3485","journal-title":"BMC Public Health"},{"issue":"10184","key":"9993_CR55","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"S-E Al-Batran","year":"2019","unstructured":"Al-Batran S-E et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet 393(10184):1948\u20131957","journal-title":"Lancet"},{"issue":"33","key":"9993_CR56","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako M et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29(33):4387\u20134393","journal-title":"J Clin Oncol"},{"issue":"19","key":"9993_CR57","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","volume":"30","author":"SR Smalley","year":"2012","unstructured":"Smalley SR et al (2012) Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 30(19):2327","journal-title":"J Clin Oncol"},{"issue":"5","key":"9993_CR58","first-page":"544","volume":"6","author":"B Shan","year":"2015","unstructured":"Shan B et al (2015) Systematic review on quality of life outcomes after gastrectomy for gastric carcinoma. J Gastrointest Oncol 6(5):544\u2013560","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"9993_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jval.2019.12.004","volume":"23","author":"R Ara","year":"2020","unstructured":"Ara R et al (2020) Are current reporting standards used to describe health state utilities in cost-effectiveness models satisfactory? Value Health 23(3):397\u2013405","journal-title":"Value Health"},{"issue":"7","key":"9993_CR60","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jval.2023.05.003","volume":"26","author":"CJ Edgar","year":"2023","unstructured":"Edgar CJ et al (2023) Recommendations on the selection, development, and modification of performance outcome assessments: a good practices report of an ISPOR task force. Value Health 26(7):959\u2013967","journal-title":"Value Health"},{"issue":"6","key":"9993_CR61","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/14737167.2019.1596027","volume":"19","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O (2019) Prognostic impact of baseline quality of life status among patients with advanced gastric cancer; results from two randomized studies. Expert Rev Pharmacoecon Outcomes Res 19(6):711\u2013715","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"9993_CR62","first-page":"5943","volume":"28","author":"C Hirose","year":"2020","unstructured":"Hirose C et al (2020) Real-world data of the association between quality of life using the EuroQol 5 dimension 5 level utility value and adverse events for outpatient cancer chemotherapy. Support Care Cancer 28:5943\u20135952","journal-title":"Support Care Cancer"},{"key":"9993_CR63","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1007\/s12325-020-01358-2","volume":"37","author":"S Mitani","year":"2020","unstructured":"Mitani S et al (2020) A phase II study of modified FOLFOX6 for advanced gastric cancer refractory to standard therapies. Adv Ther 37:2853\u20132864","journal-title":"Adv Ther"},{"key":"9993_CR64","doi-asserted-by":"crossref","unstructured":"Kawabata R et al. (2022) Survival analysis of a prospective multicenter observational study on surgical palliation among patients with malignant bowel obstruction caused by peritoneal dissemination of gastric cancer. Gastric Cancer 1\u20138","DOI":"10.1007\/s10120-021-01251-z"},{"issue":"1","key":"9993_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-022-02032-7","volume":"20","author":"M Su","year":"2022","unstructured":"Su M et al (2022) Frailty and its association with health-related quality of life among older cancer patients: an evidence-based study from China. Health Qual Life Outcomes 20(1):1\u20139","journal-title":"Health Qual Life Outcomes"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09993-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09993-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09993-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:04:25Z","timestamp":1760673865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09993-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9993"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09993-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"907"}}